Chromosome 22q11.2 deletion is the most common chromosomal alteration associated with DiGeorge syndrome (DGS), even though this is not the only underlying cause of DGS. In rare patients, mutations in a single gene, TBX1, have been described resulting in a DGS phenotype.
| INTRODUCTION
DiGeorge syndrome (DGS), also known as 22q11.2 deletion syndrome (22q11.2 DS) was first described in the 1960s and classically comprises facial anomalies, hypoparathyroidism, cardiac malformations, developmental, and speech delay, and mild to moderate immune deficiency related to thymic a/hypoplasia (Cancrini et al., 2014) . Chromosome 22q11.2 deletion is the most common chromosomal alteration associated with DGS, occurring in approximately 1:4,000 live births (Cirillo et al., 2014; Tezenas Du Montcel, Mendizabai, Ayme, Levy, & Philip, 1996) . However, a small number of patients affected with other genetic syndromes share a few clinical features with the 22q11 spectrum, including Opitz G/BBB (McDonald-MCGinn et al., 1995; Robin, Opitz, & Muenke, 1996) and CHARGE syndrome (Devriendt, Fryns, Mortier, van Thienen, & Keymolen, 1998) , and other chromosomal deletions as 16p11.2, 10p13, 17p13, 4q34.1q35.2 (Ballif et al., 2007; Cuturilo et al., 2011; Greenberg, Elder, Haffner, Northrup, & Ledbetter, 1988; Pignata et al., 1996) .
Teratogenic influences such as maternal diabetes (Wilson et al., 1993) or prenatal exposure to retinoic acid or alcohol may also lead to a DiGeorge anomaly (DGA). However, only a minority of newborns of diabetic mothers have a DGA, thus implying the requirement for multiple factors for the expression of this anomaly. In rare patients with a DGS phenotype but without the 22q11.2 deletion, mutations in the single T-box (TBX1) gene, which plays an important role in regulating the expression of several transcription factors, have been Am J Med Genet. 2017; 173A:1913 -1918 wileyonlinelibrary.com/journal/ajmga described (Yagi et al., 2003) . However, in some patients with a presumed diagnosis of DGS, the underlying etiology cannot be identified (Rope, Cragun, Saal, & Hopkin, 2009 (Busse et al., 2010) .
We report on a child born to a mother with gestational diabetes mellitus (GDM) affected with a DGA, associated with a 3p12.3 deletion, involving the ZNF717, MIR1243, and 4273 genes, which have a role in the regulation of embryogenesis. Among the miRNA-4273 predicted target genes, there is the bone morphogenetic protein-3 (BMP3), which is involved in several steps of embryogenesis, including kidney and lung. We hypothesize that this alteration may act as a genetic cofactor in favoring the clinical expression of the DGA in newborns of diabetic mothers.
| CLINICAL REPORT
The proband is a 7-year-old Caucasian male referred to our 9-11 mg/dl) and the electrolytes were normal. Therapy with calcium and alpha-calcidiol was successfully started. An echocardiogram showed a patent oval foramen. Cerebral ultrasonography revealed a cyst of the septum pellucidum.
At 24 months, growth and head circumference were normal.
Dysmorphic features included long face, a small nose with a normal bridge, long philtrum, highly arched palate, and dental enamel dysplasia (Figure 1a, b) . No other craniofacial findings such as, bulbous nasal tip and prominent nasal root, hypoplastic alae nasae, hooded eyelids, cupped and protuberant ears, preauricular pits or tags, or craniosynostosis, which are frequently reported in children with 22q11.2DS, were detected in the patient.
The chest and abdominal examination was normal. A speech delay was observed during the first years of life. At the age of 4 years, expressive language was characterized by a sporadic use of short sentences consisting of 2-3 words, with oculomotor difficulties and abnormalities of perceptual organization. The language impairment was associated with an inhibited temperament and signs of anxiety.
However, comprehensive language was appropriate for age. Psychomotor development assessed by Griffith Mental Developmental ScaleExtended Revised (GMDS-ER) was normal (IQ = 86). The patient received psychomotor and speech therapy, resulting in a progressive improvement of the expressive language, even though it remained poorly structured.
Since, the age of 15 months, the patient had recurrent and frequent episodes of URIs. The ear-nose-throat evaluation did not reveal any hearing loss. Ophthalmologic examination was normal. Gbanded chromosomal analysis on peripheral blood lymphocytes indicated a normal karyotype.
Fluorescent in situ hybridization performed to exclude a 22q11.2 deletion syndrome and TBX1 sequencing were both negative.
3 | METHODOLOGY AND RESULTS The brackets indicate normal values for age; ND, not done. Despite consistently normal serum levels of IgM, IgG IgA, and IgE, the patient had an absent antibody specific production toward Hepatitis B. Autoantibodies to anti-thyroglobulin (TGB-Ab),
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anti-thyroid peroxidase (TPO-Ab), anti-nuclear (ANA), anti-double stranded DNA (dsDNA), and anti-transglutaminase were all negative.
| DISCUSSION
In this study, we report a novel association between a DGA characterized by a quantitative and qualitative immunodeficiency resembling a T low B + NK+ combined immunodeficiency in a child with a 3p12.3 deletion born to a mother with GDM.
Diabetic embryopathy encompasses a wide spectrum of congenital anomalies with a multifactorial pathogenesis (Castori, 2013) .
Holoprosencephaly, caudal dysgenesis, VACTERL association, and cardiovascular congenital abnormalities are the most common features associated with diabetic embryopathy. Furthermore, renal dysgenesis has been frequently reported in newborns of diabetic mothers. Moreover, DGA has also been reported in newborns of diabetic mothers (Dentici et al., 2013; Novak, Robert, & Robinson, 2005) . In these patients, unilateral o bilateral renal agenesis has also been found, suggesting a non-random association between the two events.
To date, cytogenetic studies in patients with DGA born to diabetic mothers have either not been done or have failed to identify an underlying genetic alteration.
The etiology of diabetic embryopathy is multifactorial and results from the interplay between uterine microenvironment, parental and offspring genomes, and epigenetic regulation (Castori, 2013; Vrachnis et al., 2012) . It has been hypothesized that alterations of the metabolic homeostasis associated with DM could profoundly affect several signal transduction pathways and morphogenetic processes (Castori, 2013) , thus resulting in developmental field defects. Altered expression of developmental control genes, as Pax3, has been reported in mouse models of diabetic embryopathy. However, a molecular mechanism underlying the phenotypic spectrum of DM-associated structural anomalies in humans has not been reported yet. Of note, even though several studies documented a high teratogenic potential for women with pre-gestational DM type 1 (DM1) or 2 (DM2), pregnant women developing GDM have an overall very low risk for fetal congenital anomalies, suggesting the requirement of further pathogenetic cofactors (Balsells, Garcia-Patterson, Gich, & Corcoy, 2012) . In our study, we found a novel interstitial deletion at 3p12.3 encompassing three genes, ZNF717, MIR1243 and MIR4273 in a patient with multiple congenital anomalies born to a mother whose pregnancy was complicated by GDM. MiRNAs are a family of small, non-coding (Zhang, Wang, & Gameinhart, 2013 DGCR8 encodes a component of the microprocessor complex involved in miRNA biogenesis, which is deleted in the majority of patients with 22q11.2DS (Sellier et al., 2014) . Furthermore, it has been recently demonstrated that the haploinsufficiency of miRNA-17-92 due to a germline hemizygous deletion of MIR17HG is responsible for several developmental abnormalities observed in some patients with microcephaly, short stature, and digital abnormalities (De Pontual et al., 2012) .
Evidence also indicates that miRNAs may modulate the expression of critical T-box transcriptional regulators during midface development and the BMPs. Part of the TBX1 mutant phenotype is due to excessive Bmp-signaling (Wang et al., 2013) . Interestingly, BMP3, a member of the transforming growth factor β superfamily, which plays a key role during embryogenesis, and in particular, in the development of the organs that require an epithelial-mesenchymal interaction (such as the thymus and kidney) is among the miRNA-4273 predicted target genes (Takahashi & Ikeda, 1996) .
More recently, it has been reported that BMP3 has a role in the regulation of insulin gene expression in pancreatic beta-cells as well (Bonner et al., 2011) . However, a clear causative relationship between haploinsufficiency of ZNF717 and the patient's clinical phenotype was not found.
In conclusion, we report for the first time on the association between a DGA in an infant born to a mother with GDM and a microdeletion of chromosome 3, involving the MIR4273 gene. Even though the causal relationship between the two events remains to be proven, our report provides further support for the multifactorial pathogenesis of DGA associated with GDM.
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